Efficacy and safety of Alefacept in combination with Tacrolimus, Mycophenolate Mofetil and Steroids in de-novo kidney transplantation - a multicenter, randomized, double-blind, placebo controlled, parallel group study Efficacy and safety of Alefacept in combination with Tacrolimus, Mycophenolate Mofetil and Steroids in de-novo kidney transplantation - a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Trial Profile

Efficacy and safety of Alefacept in combination with Tacrolimus, Mycophenolate Mofetil and Steroids in de-novo kidney transplantation - a multicenter, randomized, double-blind, placebo controlled, parallel group study Efficacy and safety of Alefacept in combination with Tacrolimus, Mycophenolate Mofetil and Steroids in de-novo kidney transplantation - a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Alefacept (Primary) ; Alefacept (Primary) ; Corticosteroids; Mycophenolate mofetil; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 03 Jun 2013 Primary endpoint 'Biopsy-proven-acute-transplant-rejection' has not been met.
    • 24 Mar 2012 This trial has been recruiting in France, Czech Republic, United Kingdom and Spain.
    • 07 Sep 2011 Results presented at the 15th Congress of the European Society for Organ Transplantation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top